Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 114,251,365
- Total 13F value
- $337,827,363
- Share change
- -2,087,102
- Put/Call ratio
- 169%
- SEC-reported price per share
- $2.96
- Number of holders
- 146
- Value change
- -$12,985,717
- Number of buys
- 57
- Number of sells
- 71
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
146
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 9%
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
9%
BAILLIE GIFFORD & CO
7.6%
VOYA INVESTMENT MANAGEMENT LLC
3.5%
Capital World Investors
2.7%
CREDIT SUISSE AG/
1.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
9%
|
$124,691,149
27,525,640 shares
|
— | 31 Mar 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
7.6%
|
$105,005,803
23,180,089 shares
|
— | 31 Mar 2024 |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
Company
|
3.5%
|
$48,127,558
10,624,185 shares
|
— | 31 Mar 2024 |
| Capital World Investors |
13F
Company
|
2.7%
|
$37,831,357
8,351,293 shares
|
— | 31 Mar 2024 |
| CREDIT SUISSE AG/ |
13F
Company
|
1.5%
|
$20,599,337
4,547,315 shares
|
— | 31 Mar 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.4%
|
$18,938,879
4,180,768 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
146
Shares
114,251,365
Rows available
146
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
153
Q2 2024 holders
146
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|